About Synapse
Overview
Disclaimer
Journal list
Advanced
Contact us
Search Guidelines
How to Participate
How to add a journal to Synapse
How to submit a file after validating the JATS XML file
File Validation tools
KAMJE Databases
KoreaMed
KoMCI
Korean Medical Journal Information
KAMJE
About Synapse
Overview
Disclaimer
Journal list
Advanced
Contact us
Search Guidelines
How to Participate
How to add a journal to Synapse
How to submit a file after validating the JATS XML file
File Validation tools
KAMJE Databases
KoreaMed
KoMCI
Korean Medical Journal Information
KAMJE
-Advanced
-Search Guidelines
Home
Journal List
Transl Clin Pharmacol
Go to Top
Go to Top
Go to Bottom
Go to Bottom
Transl Clin Pharmacol >
v.27(1)
7 results
1
Translational and Clinical Pharmacology: Note from the new Editor-in-Chief
Translational and Clinical Pharmacology: Note from the new Editor-in-Chief
Sang-Goo Shin
Sang-Goo Shin
KMSID: 1138135
Transl Clin Pharmacol.
2019;27(1):1-1. Published online 2019 March 27 DOI:
http://dx.doi.org/10.12793/tcp.2019.27.1.1
2
Expert clinical consulting for early drug development programs in Korea
Expert clinical consulting for early drug development programs in Korea
Hanlim Moon
Hanlim Moon
KMSID: 1138136
Transl Clin Pharmacol.
2019;27(1):2-5. Published online 2019 March 27 DOI:
http://dx.doi.org/10.12793/tcp.2019.27.1.2
6
Digital therapeutics and clinical pharmacology
Digital therapeutics and clinical pharmacology
Jae-Yong Chung
Jae-Yong Chung
KMSID: 1138377
Transl Clin Pharmacol.
2019;27(1):6-11. Published online 2019 March 27 DOI:
http://dx.doi.org/10.12793/tcp.2019.27.1.6
12
Introduction to
in silico
model for proarrhythmic risk assessment under the CiPA initiative
Introduction to
in silico
model for proarrhythmic risk assessment under the CiPA initiative
Jin-Sol Park, Ji-Young Jeon, Ji-Ho Yang, Min-Gul Kim
Jin-Sol Park, Ji-Young Jeon, Ji-Ho Yang, Min-Gul Kim
KMSID: 1138380
Transl Clin Pharmacol.
2019;27(1):12-18. Published online 2019 March 27 DOI:
http://dx.doi.org/10.12793/tcp.2019.27.1.12
19
Evolving role of modeling and simulation in drug development
Evolving role of modeling and simulation in drug development
Hyeong-Seok Lim
Hyeong-Seok Lim
KMSID: 1119825
Transl Clin Pharmacol.
2019;27(1):19-23. Published online 2019 March 27 DOI:
http://dx.doi.org/10.12793/tcp.2019.27.1.19
24
Characterization of circadian blood pressure patterns using non-linear mixed effects modeling
Characterization of circadian blood pressure patterns using non-linear mixed effects modeling
Dongwoo Chae, Yukyung Kim, Kyungsoo Park
Dongwoo Chae, Yukyung Kim, Kyungsoo Park
KMSID: 1119827
Transl Clin Pharmacol.
2019;27(1):24-32. Published online 2019 March 27 DOI:
http://dx.doi.org/10.12793/tcp.2019.27.1.24
33
Quantification of apixaban in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry
Quantification of apixaban in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry
Hyeon-Cheol Jeong, Tae-Eun Kim, Kwang-Hee Shin
Hyeon-Cheol Jeong, Tae-Eun Kim, Kwang-Hee Shin
KMSID: 1138385
Transl Clin Pharmacol.
2019;27(1):33-41. Published online 2019 March 27 DOI:
http://dx.doi.org/10.12793/tcp.2019.27.1.33
Articles from Translational and Clinical Pharmacology are provided here courtesy of Korean Society for Clinical Pharmacology and Therapeutics